Associate Professor David Reith

2025

Journal - Research Article

Illamola, S. M., Bhongsatiern, J., Birnbaum, A. K., Kumar, S. S., Courter, J. D., Haslam, D. B., … Reith, D. M., … Sherwin, C. M. (2025). Vancomycin dosing in neonates: Enhancing outcomes using population pharmacokinetics and simulation. Frontiers in Antibiotics, 4, 1568931. doi: 10.3389/frabi.2025.1568931

2023

Journal - Research Article

Reith, D. M., Leitch, S., Eggleton, K., Wallis, K., Lillis, S., Williamson, M., & Cunningham, W. (2023). Treatment harms in paediatric primary care. International Journal of Environmental Research & Public Health, 20(14), 6378. doi: 10.3390/ijerph20146378

Chin, P. K. L., Charles, K., Murnion, B., McGuire, T. M., Hilmer, S. N., Martin, J., Reith, D., … Doogue, M., … O'Mara, D. (2023). Evaluation of the Prescribing Skills Assessment implementation, performance and medical student experience in Australia and New Zealand. British Journal of Clinical Pharmacology, 89, 3105-3115. doi: 10.1111/bcp.15814

Kremer, L. J., Medlicott, N., Sime, M. J., Broadbent, R., Edmonds, L., Berry, M. J., Austin, N. C., … Reith, D. M. (2023). Low dose or very low dose phenylephrine and cyclopentolate microdrops for retinopathy of prematurity eye examinations (The Little Eye Drop Study): A randomised controlled non-inferiority trial. Archives of Disease in Childhood: Fetal & Neonatal Edition, 108, F380-F386. doi: 10.1136/archdischild-2022-324929

Conference Contribution - Published proceedings: Full paper

Yogarajan, V., Dobbie, G., Leitch, S., & Reith, D. (2023). Developing a fair AI-based healthcare framework with feedback loop. In Z. Ibrahim, H. Wu & N. Wiratunga (Eds.), Proceedings of the 6th International Workshop on Knowledge Discovery from Healthcare Data (KDH@IJCAI) [CEUR Workshop Proceedings: Vol. 3479]. CEUR-WS. Retrieved from https://ceur-ws.org

Conference Contribution - Published proceedings: Abstract

Reith, D., Leitch, S., Wallis, K., Cunningham, W., Williamson, M., Eggleton, K., & Lillis, S. (2023). Paediatric harms observed in a retrospective review of general practice records in Aotearoa New Zealand. Australian Journal of Primary Health, 29(4), (pp. lxii). doi: 10.1071/PYv29n4abs

Kremer, L. J., Edmonds, L. K., Sime, M. J., Broadbent, R. S., Medlicott, N. J., Berry, M. J., Austin, N. C., … Reith, D. M. (2023). The Little Eye Drop Study: Are very low dose mydriatics in a microdrop effective and safe for ROP eye examinations? Journal of Paediatrics & Child Health, 59(Suppl. 1), (pp. 89). doi: 10.1111/jpc.16357

Conference Contribution - Verbal presentation and other Conference outputs

Reith, D. (2023, August-September). Use of R-shiny apps to enhance learning of core concepts in pharmacology. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.

2022

Journal - Research Article

Yogarajan, V., Dobbie, G., Leitch, S., Keegan, T. T., Bensemann, J., Witbrock, M., … Reith, D. (2022). Data and model bias in artificial intelligence for healthcare applications in New Zealand. Frontiers in Computer Science, 4, 1070493. doi: 10.3389/fcomp.2022.1070493

Kremer, L., Reith, D., Medlicott, N. J., Sime, M. J., Edmonds, L., & Broadbent, R. (2022). A survey of neonatal nurses on mydriatic regimens used in neonatal retinopathy of prematurity eye examinations. American Journal of Perinatology, 39(16), 1779-1785. doi: 10.1055/s-0041-1726316

2021

Journal - Research Article

Leitch, S., Dovey, S., Cunningham, W., Wallis, K., Eggleton, K., Lillis, S., McMenamin, A., Williamson, M., Reith, D., Samaranayaka, A., & Tilyard, M. (2021). Epidemiology of healthcare harm in New Zealand general practice: A retrospective records review study. BMJ Open, 11, e048316. doi: 10.1136/bmjopen-2020-048316

Leitch, S., Dovey, S. M., Cunningham, W. K., Smith, A. J., Zeng, J., Reith, D. M., … Williamson, M. I., & Lillis, S. (2021). Medication-related harm in New Zealand general practice: A retrospective records review. British Journal of General Practice, e626-e633. doi: 10.3399/bjgp.2020.1126

Kremer, L. J., Broadbent, R., Medlicott, N., Sime, M. J., McCaffrey, F., & Reith, D. M. (2021). Randomised controlled pilot trial comparing low dose and very low- dose microdrop administration of phenylephrine and cyclopentolate for retinopathy of prematurity eye examinations in neonates. Archives of Disease in Childhood, 106, 603-608. doi: 10.1136/archdischild-2019-318733

Journal - Research Other

Kremer, L., Reith, D., Medlicott, N. J., Sime, M. J., Edmonds, L., & Broadbent, R. (2021). Microdrop administration of mydriatics may reduce the risk of NEC. Pediatrics International, 63(6), 741. doi: 10.1111/ped.14620

2020

Journal - Research Article

Simpson, B. H., Reith, D. M., Medlicott, N. J., & Smith, A. J. (2020). Monitoring the use of dabigatran etexilate for stroke prevention: Compliance with renal function guidelines. Journal of Primary Health Care, 12(4), 327-334. doi: 10.1071/HC19115

Fountain, J. S., Tomlin, A. M., Reith, D. M., & Tilyard, M. W. (2020). Fatal toxicity indices for medicine-related deaths in New Zealand, 2008-2013. Drug Safety, 43, 223-232. doi: 10.1007/s40264-019-00885-4

Journal - Research Other

Chiew, A. L., Reith, D., Pomerleau, A., Wong, A., Isoardi, K. Z., Soderstrom, J., & Buckley, N. A. (2020). Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand. Medical Journal of Australia, 212(4), 175-183. doi: 10.5694/mja2.50428

2019

Journal - Research Article

Simpson, B. H., Reith, D. M., Medlicott, N. J., & Smith, A. J. (2019). Exposure response supports therapeutic drug monitoring for dabigatran etexilate in patients with atrial fibrillation. TH Open, 3(3), e210-e215. doi: 10.1055/s-0039-1693486

Ritchie, D., Broadbent, R., Medlicott, N., & Reith, D. M. (2019). In vitro validation of a method for neonatal urine collection and analysis. BMJ Paediatrics Open, 3(1), e000482. doi: 10.1136/bmjpo-2019-000482

Richards, N., Reith, D., Stitely, M., & Smith, A. (2019). The Before School Check (B4SC): Reporting outcomes and referral rates for all New Zealand children. New Zealand Medical Journal, 132(1496), 9-19. Retrieved from https://www.nzma.org.nz/journal

Kremer, L. J., Reith, D. M., Medlicott, N., & Broadbent, R. (2019). Systematic review of mydriatics used for screening of retinopathy in premature infants. BMJ Paediatrics Open, 3(1), 3000448. doi: 10.1136/bmjpo-2019-000448

Dainty, G. J., Reith, D. M., & Taylor, B. J. (2019). Management of childhood obesity: An audit of clinical practice in secondary care. Journal of Paediatrics & Child Health, 55(10), 1224-1229. doi: 10.1111/jpc.14385

Richards, N., Reith, D., Stitely, M., & Smith, A. (2019). Developmental outcomes at age four following maternal antiepileptic drug use. Epilepsy & Behavior, 93, 73-79. doi: 10.1016/j.yebeh.2019.01.018

Fountain, J. S., Reith, D. M., Tomlin, A. M., Smith, A. J., & Tilyard, M. W. (2019). Deaths by poisoning in New Zealand, 2008-2013. Clinical Toxicology, 57(11), 1087-1094. doi: 10.1080/15563650.2019.1582777

Dainty, G. J., Reith, D. M., & Taylor, B. J. (2019). Introduction and uptake of electronic growth charts in southern New Zealand. Journal of Paediatrics & Child Health, 55, 421-427. doi: 10.1111/jpc.14217

Conference Contribution - Published proceedings: Abstract

Kremer, L., Reith, D., Medlicott, N., & Broadbent, R. (2019). Very low doses of phenylephrine and cyclopentolate eye drops sufficiently dilate the pupil for ROP eye examinations. Journal of Paediatrics & Child Health, 55(Suppl. 1), (pp. 28). doi: 10.1111/jpc.14406

Reith, D., Tomlin, A., Fountain, J., & Tilyard, M. (2019). Pharmacovigilance study of clozapine in New Zealand using three outcomes databases. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Population Approach Group of Australia and New Zealand (PAGANZ) Joint Scientific Meeting: Shared Horizons: Optimizing Drug Response to Improve Patient Outcomes. (pp. 8). Retrieved from https://www.asceptasm.com

Salis, G., Medlicott, N., & Reith, D. (2019). Modelling of delivery kinetics of gentamicin administered through umbilical long lines. Proceedings of the 20th Annual Population Approach Group in Australia and New Zealand Meeting (PAGANZ). (pp. 18-19). Retrieved from https://www.paganz.org/auckland-2019

Simpson, B., Reith, D., Medlicott, N., & Smith, A. (2019). Estimated exposure to dabigatran etexilate influences efficacy and toxicity. European Journal of Clinical Pharmacology, 75(Suppl. 1), (pp. S90). doi: 10.1007/s00228-019-02685-2

Simpson, B., Reith, D., Medlicott, N., & Smith, A. (2019). Poor adherence to renal function testing for dabigatran. European Journal of Clinical Pharmacology, 75(Suppl. 1), (pp. S28-S29). doi: 10.1007/s00228-019-02685-2

2018

Journal - Research Article

Simpson, B. H., Reith, D., Medlicott, N. J., & Smith, A. (2018). Deprivation and inequalities lead to worse outcomes with dabigatran etexilate. Journal of Primary Health Care, 10(4), 303-311. doi: 10.1071/HC17081

Simpson, B. H., Reith, D. M., Medlicott, N. J., & Smith, A. J. (2018). Choice of renal function estimator influences adverse outcomes with dabigatran etexilate in patients with atrial fibrillation. TH Open, 2(04), e420-e427. doi: 10.1055/s-0038-1676356. ISSN 2512-9465

Muller, M., Wheeler, B. J., Blackwell, M., Colas, M., Reith, D. M., Medlicott, N. J., & Al-Sallami, H. S. (2018). The influence of patient variables on insulin total daily dose in paediatric inpatients with new onset type 1 diabetes mellitus. Journal of Diabetes & Metabolic Disorders, 17, 159-163. doi: 10.1007/s40200-018-0355-5

Leitch, S., Dovey, S. M., Samaranayaka, A., Reith, D. M., Wallis, K. A., Eggleton, K. S., … Williamson, M. I., … Tilyard, M. W. (2018). Characteristics of a stratified random sample of New Zealand general practices. Journal of Primary Health Care, 10(2), 114-124. doi: 10.1071/HC17089

Richards, N., Reith, D., Stitely, M., & Smith, A. (2018). Antiepileptic drug exposure in pregnancy and pregnancy outcome from national drug usage data. BMC Pregnancy & Childbirth, 18(1), 84. doi: 10.1186/s12884-018-1728-y

Healey, D., Gray, A. R., Chae, M., Taylor, B. J., Lawrence, J., Reith, D. M., & Wheeler, B. J. (2018). The role of parent and child self-regulation in children’s glycemic control. Health Psychology, 37(4), 326-333. doi: 10.1037/hea0000554

Richards, N., Reith, D., Stitely, M., & Smith, A. (2018). Are doses of lamotrigine or levetiracetam adjusted during pregnancy? Epilepsia Open, 3(1), 86-90. doi: 10.1002/epi4.12086

Journal - Research Other

Reith, D. M., & Al-Sallami, H. S. (2018). Comment on van Rongen et al., "Higher midazolam clearance in obese adolescents compared with morbidly obese adults". Clinical Pharmacokinetics, 57, 1355. doi: 10.1007/s40262-018-0691-0

Reith, D. M. (2018). Comment on: “Morbidly obese patients exhibit increased CYP2E1-mediated oxidation of acetaminophen”. Clinical Pharmacokinetics, 57, 895-896. doi: 10.1007/s40262-018-0666-1

Conference Contribution - Published proceedings: Abstract

Dainty, G., Reith, D., & Taylor, B. (2018). Kids BMI study: Evaluation of community interventions for pre-schoolers with high BMI in the South Island. Proceedings of the Paediatric Society of New Zealand 70th Annual Scientific Meeting. (pp. 76). Retrieved from http://www.psnz2018.co.nz

Dainty, G., Reith, D., & Taylor, B. (2018). Kids BMI study: Parental experiences of the growth assessment in the B4SC. Proceedings of the Paediatric Society of New Zealand 70th Annual Scientific Meeting. (pp. 27). Retrieved from http://www.psnz2018.co.nz

2017

Journal - Research Article

Salis, E. R., Reith, D. M., Wheeler, B. J., Broadbent, R. S., & Medlicott, N. J. (2017). Hyperglycaemic preterm neonates exhibit insulin resistance and low insulin production. BMJ Paediatrics Open, 1(1), e000160. doi: 10.1136/ bmjpo-2017-000160

Tomlin, A. M., Reith, D. M., Woods, D. J., Lloyd, H. S., Smith, A., Fountain, J. S., & Tilyard, M. W. (2017). A pharmacoepidemiology database system for monitoring risk due to the use of medicines by New Zealand primary care patients. Drug Safety, 40(12), 1259-1277. doi: 10.1007/s40264-017-0579-1

Constance, J. E., Reith, D., Ward, R. M., Balch, A., Stockmann, C., Korgenski, E. K., … Sherwin, C. M. T. (2017). Risk of nonsteroidal anti-inflammatory drug-associated renal dysfunction among neonates diagnosed with patent ductus arteriosus and treated with gentamicin. Journal of Perinatology, 37, 1093-1102. doi: 10.1038/jp.2017.80

Salis, E. R., Reith, D. M., Wheeler, B. J., Broadbent, R. S., & Medlicott, N. J. (2017). Insulin resistance, glucagon-like peptide-1 and factors influencing glucose homeostasis in neonates. Archives of Disease in Childhood: Fetal & Neonatal Edition, 102(2), F162-F166. doi: 10.1136/archdischild-2015-309174

Journal - Research Other

Jayathissa, S., Dixon, P., Bruce, R., & Reith, D. (2017). Refining metformin prescribing in New Zealand. New Zealand Medical Journal, 130(1452), 49-53. Retrieved from https://www.nzma.org.nz/journal

Dovey, S. M., Leitch, S., Wallis, K. A., Eggleton, K. S., Cunningham, W. K., Williamson, M. I., … Tilyard, M. W., Reith, D. M., Samaranayaka, A., & Hall, J. E. (2017). Epidemiology of patient harms in New Zealand: Protocol of a general practice records review study. JMIR Research Protocols, 6(1), e10. doi: 10.2196/resprot.6696

Conference Contribution - Published proceedings: Abstract

Richards, N., Smith, A., Reith, D., & Stitely, M. (2017). Antiepileptic drug exposure in pregnancy and pregnance outcome from national drug usage data. International Journal of Integrated Care, 17(3), A28. doi: 10.5334/ijic.3140

Gandhi, P., Wheeler, B., Edmonds, L., Medlicott, N., Broadbent, R., Reith, D., & Al-Sallami, H. (2017). Neonatal hyperglycaemia management: Current practice in Australia and New Zealand. Proceedings of the University of Otago Student Research Symposium: Te Wānaka Rakahau: Ākoka. (pp. 27). Retrieved from http://www.otago.ac.nz/graduate-research/scholarships/otago643219.html

Dowd, L., Wheeler, B., Al-Sallami, H., Broadbent, R., Edmonds, L., Reith, D., & Medlicott, N. (2017). Paracetamol treatment for patent ductus arteriosus: Current clinical practices and attitudes. Proceedings of the University of Otago Student Research Symposium: Te Wānaka Rakahau: Ākoka. (pp. 19-20). Retrieved from http://www.otago.ac.nz/graduate-research/scholarships/otago643219.html

Simpson, B., Reith, D., Medlicott, N., & Smith, A. (2017). Utilisation of New Zealand primary care electronic data to guide clinical decision support system design: A retrospective cohort for dabigatran. Clinical Therapeutics, 39(8, Suppl.), (pp. e7). doi: 10.1016/j.clinthera.2017.05.024

Simpson, B., Reith, D., Medlicott, N., & Smith, A. (2017). Choice of renal function estimator may affect adverse outcomes with dabigatran. Clinical Therapeutics, 39(8, Suppl.), (pp. e7). doi: 10.1016/j.clinthera.2017.05.023

Richards, N., Reith, D., Stitely, M., & Smith, A. (2017). Are doses of lamotrigine or levetiracetam adjusted during pregnancy? Clinical Therapeutics, 39(8, Suppl.), (pp. e46). doi: 10.1016/j.clinthera.2017.05.142

Reith, D., Simpson, B., Medlicott, N., & Smith, A. (2017). Dabigatran exposure and outcomes: A PK/PD/PV study. Clinical Therapeutics, 39(8, Suppl.), (pp. e8). doi: 10.1016/j.clinthera.2017.05.026

Conference Contribution - Verbal presentation and other Conference outputs

Reith, D., Simpson, B., Medlicott, N., & Smith, A. (2017, September). Prediction of drug exposure in pharmacoepidemiology studies: Dabigatran as a case study. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.

2016

Journal - Research Article

Salis, E. R., Reith, D. M., Broadbent, R. S., & Medlicott, N. J. (2016). Haematocrit influences insulin concentration measurements in dried blood spots. Journal of Maternal-Fetal & Neonatal Medicine, 29(19), 3208-3211. doi: 10.3109/14767058.2015.1119116

Wheeler, B. J., Lawrence, J., Chae, M., Paterson, H., Gray, A. R., Healey, D., Reith, D. M., & Taylor, B. J. (2016). Intuitive eating is associated with glycaemic control in adolescents with type I diabetes mellitus. Appetite, 96, 160-165. doi: 10.1016/j.appet.2015.09.016

Linakis, M. W., Roberts, J. K., Lala, A. C., Spigarelli, M. G., Medlicott, N. J., Reith, D. M., … Sherwin, C. M. T. (2016). Challenges associated with route of administration in neonatal drug delivery. Clinical Pharmacokinetics, 55(2), 185-196. doi: 10.1007/s40262-015-0313-z

Salis, E. R., Soelbeck, M. K., Reith, D. M., Wheeler, B. J., Broadbent, R. S., & Medlicott, N. J. (2016). Effect of gestational age and blood glucose on C-peptide excretion rate and clearance in neonates. Journal of Paediatrics & Child Health, 52(1), 60-66. doi: 10.1111/jpc.12977

Chae, M., Taylor, B. J., Lawrence, J., Healey, D., Reith, D. M., Gray, A., & Wheeler, B. J. (2016). Family CHAOS is associated with glycaemic control in children and adolescents with type 1 diabetes mellitus. Acta Diabetologica, 53(1), 49-55. doi: 10.1007/s00592-015-0736-x

Journal - Research Other

Young, A., Tordoff, J., Dovey, S., Reith, D., Lloyd, H., Tilyard, M., & Smith, A. (2016). Using an electronic decision support tool to reduce inappropriate polypharmacy and optimize medicines: rationale and methods. JMIR Research Protocols, 5(2), e105. doi: 10.2196/resprot.5543

Conference Contribution - Published proceedings: Abstract

Dainty, G., Reith, D., & Taylor, B. (2016). Childhood obesity: E-growth chart monitoring in secondary care. Proceedings of the Paediatric Society of New Zealand 68th Annual Scientific Meeting. (pp. 61). Retrieved from http://www.paediatrics.org.nz/

Simpson, B., Reith, D., Medlicott, N., Smith, A., & Tilyard, M. (2016). New Zealand formulary for children: A case study of national paediatric formulary development. Archives of Disease in Childhood, 101, e1. doi: 10.1136/archdischild-2015-310148.25

Conference Contribution - Verbal presentation and other Conference outputs

Leitch, S., Dovey, S., Audas, R., Wallis, K., & Reith, D. (2016, September). Economic burden of patient harm observed in general practice records. Verbal presentation at the New Zealand Primary Care Research Colloquium, Whitianga, New Zealand.

2015

Journal - Research Article

Burke, M., Bernhardt, H., Reith, D. M., Barker, D., Broadbent, R. S., & Wheeler, B. J. (2015). Perinatal influences on the uptake of newborn vitamin K prophylaxis: A retrospective cohort study. Australian & New Zealand Journal of Public Health, 39(6), 573-576. doi: 10.1111/1753-6405.12399

Bernhardt, H., Barker, D., Reith, D. M., Broadbent, R. S., Jackson, P. M., & Wheeler, B. J. (2015). Declining newborn intramuscular vitamin K prophylaxis predicts subsequent immunisation refusal: A retrospective cohort study. Journal of Paediatrics & Child Health, 51(9), 889-894. doi: 10.1111/jpc.12887

Owens, K. H., Medlicott, N. J., Zacharias, M., Whyte, I. M., Buckley, N. A., & Reith, D. M. (2015). Population pharmacokinetic-pharmacodynamic modelling to describe the effects of paracetamol and N-acetylcysteine on the international normalized ratio. Clinical & Experimental Pharmacology & Physiology, 42(1), 102-108. doi: 10.1111/1440-1681.12327

Journal - Research Other

Wheeler, B. J., Taylor, B. J., Simonsen, K., & Reith, D. M. (2015). Acebutolol and immediate release melatonin in treatment of Smith-Magenis syndrome. Journal of Medical Cases, 6(4), 176-178. doi: 10.14740/jmc2102w

Ross, P. L., Milburn, J., Reith, D. M., Wiltshire, E., & Wheeler, B. J. (2015). Clinical review: Insulin pump-associated adverse events in adults and children. Acta Diabetologica, 52(6), 1017-1024. doi: 10.1007/s00592-015-0784-2

Lala, A. C., Broadbent, R. S., Medlicott, N. J., Sherwin, C. M. T., & Reith, D. M. (2015). Illustrative neonatal cases regarding drug delivery issues. Journal of Paediatrics & Child Health, 51, 478-481. doi: 10.1111/jpc.12764

Journal - Professional & Other Non-Research Articles

Chiew, A. L., Fountain, J. S., Graudins, A., Isbister, G. K., Reith, D., & Buckley, N. A. (2015). Summary statement: New guidelines for the management of paracetamol poisoning in Australia and New Zealand [Clinical focus]. Medical Journal of Australia, 203(5), 215-218. doi: 10.5694/mja15.00614

Reith, D., & Beggs, S. (2015). Fifty years of paediatric clinical pharmacology. Journal of Paediatrics & Child Health, 51(1), 28-29. doi: 10.1111/jpc.12802

Conference Contribution - Published proceedings: Abstract

Wheeler, B. J., Lawrence, J., Chae, M., Paterson, H., Gray, A., Healey, D., Reith, D. M., & Taylor, B. J. (2015). Intuitive eating is associated with glycaemic contron in adolescents with type I diabetes mellitus. Proceedings of the International Society for Pediatric and Adolescent Diabetes + Australasian Paediatric Endocrine Group (ISPAD + APEG) Joint Annual Conference: Leaping the Barriers. P193. Retrieved from http://2015.ispad.org/jointispad-apeg2015/home

Fountain, J. S., Borman, B., Masters, H. T., Read, D. A., & Reith, D. M. (2015). Decline in carbon monoxide poisoning deaths in New Zealand. Clinical Toxicology, 53(7), (pp. 697). doi: 10.3109/15563650.2015.1071025

Fountain, J. S., Borman, B., Masters, H. T., Read, D. A., & Reith, D. M. (2015). Deaths involving sedative-hypnotic medications in New Zealand. Clinical Toxicology, 53(7), (pp. 695). doi: 10.3109/15563650.2015.1071025

Fountain, J. S., Borman, B., Masters, H. T., Read, D. A., & Reith, D. M. (2015). Deaths involving antipsychotic medications in New Zealand. Clinical Toxicology, 53(7), (pp. 693-694). doi: 10.3109/15563650.2015.1071025

Leitch, S., Dovey, S., Wallis, K., Eggleton, K., Lillis, S., McMenamin, A., Williamson, M., Cunningham, W., Tilyard, M., Reith, D., & Samaranayaka, A. (2015). General practice e-records for research: To use or not to use? Proceedings of the Royal New Zealand College of General Practitioners (RNZCGP) Conference for General Practice: Imagine: Inspire: Innovate. Retrieved from http://www.generalpractice.org.nz/gp15

Salis, E. R., Soelbeck, M. K., Reith, D. M., Wheeler, B. J., Broadbent, R. S., & Medlicott, N. J. (2015). C-peptide clearance: Potential marker of endogenous insulin secretion for Pkpd studies of insulin in neonates. Clinical Therapeutics, 37(8, Suppl.), (pp. e59). doi: 10.1016/j.clinthera.2015.05.176

Conference Contribution - Poster Presentation (not in published proceedings)

Lala, A., Medlicott, N., Broadbent, R., McCaffrey, F., & Reith, D. (2015, June). Gentamicin pharmacokinetic variability is influenced by choice of administration route. Poster session presented at the 15th Biennial European Society for Developmental, Perinatal and Paediatric Pharmacology (ESDPPP) Congress, Belgrade, Serbia.

Medlicott, N., Thomas, L., Broadbent, R., & Reith, D. (2015, June). Slow infusions of gentamicin are associated with high variability in peak gentamicin concentrations in low gestation age (GA) neonates. Poster session presented at the 15th Biennial European Society for Developmental, Perinatal and Paediatric Pharmacology (ESDPPP) Congress, Belgrade, Serbia.

Salis, E. R., Reith, D. M., Broadbent, R. S., Wheeler, B. J., & Medlicott, N. J. (2015, June). Extremely premature neonates exhibit insulin resistance. Poster session presented at the 15th Biennial European Society for Developmental, Perinatal and Paediatric Pharmacology (ESDPPP) Congress, Belgrade, Serbia.

Simpson, B., Reith, D., Medlicott, N., Smith, A., & Tilyard, M. (2015, June). New Zealand formulary for children: A case study of national paediatric formulary development. Poster session presented at the 15th Biennial European Society for Developmental, Perinatal and Paediatric Pharmacology (ESDPPP) Congress, Belgrade, Serbia.

Conference Contribution - Verbal presentation and other Conference outputs

Lala, A., Medlicott, N. J., Broadbent, R. S., McCaffrey, F. T., & Reith, D. M. (2015, November). Variability in neonatal gentamicin administration influencing drug delivery kinetics. Verbal presentation at the Paediatric Society of New Zealand 67th Annual Scientific Meeting, Wellington, New Zealand.

Salis, E. R., Reith, D. M., Broadbent, R. S., Wheeler, B. J., & Medlicott, N. J. (2015, September). Extremely premature neonates exhibit insulin resistance. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.

Lala, A., Reith, D., Broadbent, R., & Medlicott, N. (2015, June). Effect of flush volume on gentamicin delivery through umbilical venous catheters. Verbal presentation at the 15th Biennial European Society for Developmental, Perinatal and Paediatric Pharmacology (ESDPPP) Congress, Belgrade, Serbia.

2014

Journal - Research Article

Fountain, J. S., Hawwari, H., Kerr, K., Holt, A., & Reith, D. (2014). Awareness, acceptability and application of paracetamol overdose management guidelines in a New Zealand emergency department. New Zealand Medical Journal, 127(1402). Retrieved from http://www.nzma.org.nz/journal

Luke, S., Fountain, J. S., Reith, D. M., Braitberg, G., & Cruickshank, J. (2014). Use of poisons information resources and satisfaction with electronic products by Victorian emergency department staff. Emergency Medicine Australasia, 26(5), 494-499. doi: 10.1111/1742-6723.12283

Owens, K. H., Murphy, P. G. M., Medlicott, N. J., Kennedy, J., Zacharias, M., Curran, N., Sreebhavan, S., Thompson-Fawcett, M., & Reith, D. M. (2014). Population pharmacokinetics of intravenous acetaminophen and its metabolites in major surgical patients. Journal of Pharmacokinetics & Pharmacodynamics, 41(3), 211-221. doi: 10.1007/s10928-014-9358-0

Wheeler, B. J., Heels, K., Donaghue, K. C., Reith, D. M., & Ambler, G. R. (2014). Insulin pump–associated adverse events in children and adolescents: A prospective study. Diabetes Technology & Therapeutics, 16(9), 558-562. doi: 10.1089/dia.2013.0388

Sherwin, C. M. T., Medlicott, N. J., Reith, D. M., & Broadbent, R. S. (2014). Intravenous drug delivery in neonates: Lessons learnt. Archives of Disease in Childhood, 99, 590-594. doi: 10.1136/archdischild-2013-304887

Lucas, C., Edmonds, L., LeRoy, J., & Reith, D. (2014). Career decisions: Factors that influence the Māori doctor. Internal Medicine Journal, 44(6), 562-567. doi: 10.1111/imj.12439

Chae, M., Reith, D. M., Tomlinson, P., Rayns, J., & Wheeler, B. J. (2014). Accuracy of verbal self-reported blood glucose in teenagers with type I diabetes at diabetes ski camp. Journal of Diabetes & Metabolic Disorders, 13, 14. doi: 10.1186/2251-6581-13-14

Fountain, J. S., Reith, D. M., & Holt, A. (2014). The utilization of poisons information resources in Australasia. International Journal of Medical Informatics, 83(2), 106-112. doi: 10.1016/j.ijmedinf.2013.10.012

Journal - Research Other

Fountain, J. S., & Reith, D. M. (2014). Dangers of "EDTA". New Zealand Medical Journal, 127(1398). Retrieved from http://www.nzma.org.nz/journal

Conference Contribution - Published proceedings: Abstract

Burke, M., Bernhardt, H., Reith, D., Barker, D., Broadbent, R., & Wheeler, B. (2014). Perinatal influences on the uptake of newborn vitamin K prophylaxis: A retrospective cohort study. Proceedings of the Paediatric Society of New Zealand 66th Annual Scientific Meeting. (pp. 79). Retrieved from http://fp2.brandish.co.nz/psnz2014/

Wheeler, B., Heels, K., Donaghue, K., Reith, D., & Ambler, G. (2014). Insulin pump-associated adverse events in children and adolescents: A prospective study. Proceedings of the Paediatric Society of New Zealand 66th Annual Scientific Meeting. (pp. 57). Retrieved from http://fp2.brandish.co.nz/psnz2014/

Lucas, C., Edmonds, L., LeRoy, J., & Reith, D. (2014). Career decisions: Factors that influence Māori doctors. Internal Medicine Journal, 44(Suppl. 3), (pp. 15). doi: 10.1111/imj.12436

Conference Contribution - Poster Presentation (not in published proceedings)

Chae, M., Reith, D. M., Tomlinson, P. A., Rayns, J., & Wheeler, B. J. (2014, May). Accuracy of verbal self-reported blood glucose in teenagers with type 1 diabetes at diabetes ski camp. Poster session presented at the New Zealand Society for the Study of Diabetes (NZSSD) Annual Scientific Meeting, Queenstown, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Reith, D. (2014, August). The influence of prematurity on insulin production indicates insulin resistance. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.

Wheeler, B. J., Heels, K., Donaghue, K. C., Reith, D. M., & Ambler, G. R. (2014, May). Insulin pump-associated adverse events in children and adolescents: A prospective study. Verbal presentation at the New Zealand Society for the Study of Diabetes (NZSSD) Annual Scientific Meeting, Queenstown, New Zealand.

2013

Journal - Research Article

Medlicott, N. J., Reith, D. M., McCaffrey, F., Krittaphol, W., & Broadbent, R. S. (2013). Delayed delivery of intravenous gentamicin in neonates: Impact of infusion variables. Journal of Pharmacy & Pharmacology, 65(3), 370-378. doi: 10.1111/jphp.12000

Journal - Research Other

Ragupathy, R., Aaltonen, K., Tordoff, J., Norris, P., & Reith, D. (2013). The authors' reply to Wonder and Milne: 'Comparing subsidized access to medicines across payer systems'. Pharmacoeconomics, 31(2), 175-176. doi: 10.1007/s40273-012-0014-5

Conference Contribution - Published proceedings: Abstract

Nguyen, A., Buzzard, S., Asmat, S., Coulter, C., Reith, D., Broadbent, R., & Kremer, L. (2013). Intravenous medicine compatibilities for neonates in intensive care. Proceedings of the Paediatric Society of New Zealand 65th Annual Scientific Meeting. (pp. 123). Retrieved from http://www.psnz2013.co.nz/

Salis, E., Reith, D., Wheeler, B., Broadbent, R., & Medlicott, N. J. (2013). Is C-peptide clearance and urinary excretion rate affected by gestational age or blood glucose concentration in neonates? Proceedings of the Paediatric Society of New Zealand 65th Annual Scientific Meeting. (pp. 94). Retrieved from http://www.psnz2013.co.nz/

Bernhardt, H., Barker, D., Reith, D., Broadbent, R., Jackson, P., & Wheeler, B. (2013). Declining newborn intramuscular vitamin K prophylaxis predicts later immunisation refusal. Proceedings of the Paediatric Society of New Zealand 65th Annual Scientific Meeting. (pp. 51). Retrieved from http://www.psnz2013.co.nz/

Wheeler, B., Chae, M., Reith, D., Tomlinson, P., & Rayns, J. (2013). Accuracy of verbal self-reported blood glucose in teenagers with type 1 diabetes at diabetes ski camp. Proceedings of the Paediatric Society of New Zealand 65th Annual Scientific Meeting. (pp. 35). Retrieved from http://www.psnz2013.co.nz/

Bhongsatiern, J., Sherwin, C. M. T., Stockmann, C., Yu, T., Reith, D. M., Desai, P. B., & Spigarelli, M. G. (2013). An external evaluation of vancomycin pharmacokinetics among septic neonates. Therapeutic Drug Monitoring, 35(5), (pp. 664). [Abstract]

Salis, E. R., Reith, D. M., Broadbent, R. S., Wheeler, B. J., & Medlicott, N. J. (2013). The effect of gestational age on the insulin to c-peptide ratio in neonates. Therapeutic Drug Monitoring, 35(5), (pp. 692). doi: 10.1097/FTD.0b013e3182a8ef2b

Lucas, C. J., Edmonds, L., LeRoy, J., & Reith, D. (2013). Career decisions: Factors that influence the Māori doctor. Proceedings of the Leaders in Indigenous Medical Education Conference: LIME Connection V: Re-imagining Indigenous Health Education: Harnessing Energy, Implementing Evidence, Creating Change. (pp. 69-70). Retrieved from http://www.limenetwork.net.au/

Conference Contribution - Poster Presentation (not in published proceedings)

Salis, E. R., Soelbeck, M. K., Reith, D. M., Broadbent, R. S., & Medlicott, N. J. (2013, August). Can a chemiluminescent immunoassay be used to measure urinary C-peptide in neonates? Poster session presented at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Reith, D. (2013, November). Pharmacovigilance for children. Verbal presentation at the Paediatric Society of New Zealand 65th Annual Scientific Meeting, Dunedin, New Zealand.

Owens, K. H., Medlicott, N. J., Whyte, I. M., Buckley, N. A., & Reith, D. M. (2013, August). Development of a population PKPD model to describe the effect of paracetamol on the International Normalised Ratio (INR). Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.

2012

Journal - Research Article

Owens, K. H., Medlicott, N. J., Zacharias, M., Chary, S., Thompson-Fawcett, M., & Reith, D. M. (2012). The pharmacokinetic profile of intravenous paracetamol in adult patients undergoing major abdominal surgery. Therapeutic Drug Monitoring, 34(6), 713-721. doi: 10.1097/FTD.0b013e31826a70ea

Ragupathy, R., Tordoff, J., Norris, P., & Reith, D. (2012). Key informants' perceptions of how PHARMAC operates in New Zealand. International Journal of Technology Assessment in Health Care, 28(4), 367-373. doi: 10.1017/s0266462312000566

Wheeler, B., Broadbent, R., & Reith, D. (2012). Premedication for neonatal intubation in Australia and New Zealand: A survey of current practice. Journal of Paediatrics & Child Health, 48(11), 997-1000. doi: 10.1111/j.1440-1754.2012.02589.x

Ragupathy, R., Aaltonen, K., Tordoff, J., Norris, P., & Reith, D. (2012). A 3-dimensional view of access to licensed and subsidized medicines under single-payer systems in the US, the UK, Australia and New Zealand. Pharmacoeconomics, 30(11), 1051-1065. doi: 10.2165/11595270-000000000-00000

Tomlin, A., Reith, D., Dovey, S., & Tilyard, M. (2012). Methods for retrospective detection of drug safety signals and adverse events in electronic general practice records. Drug Safety, 35(9), 733-743. doi: 10.2165/11631970-000000000-00000

Journal - Research Other

Kunac, D., Tatley, M. V., Grimwood, K., & Reith, D. M. (2012). Active surveillance of serious adverse drug reactions in New Zealand children. Archives of Disease in Childhood, 97(8), 761-762. doi: 10.1136/archdischild-2011-301457

Conference Contribution - Published proceedings: Abstract

Salis, E. R., Reith, D. M., & Medlicott, N. J. (2012). The effect of haematocrit on insulin levels from dried blood spots for use in clinical studies. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Australasian Pharmaceutical Science Association (APSA) Joint Conference: Medication Safety. (pp. 199). Retrieved from http://www.ascept-apsa.com/

Thomas, L. A., Medlicott, N. J., Broadbent, R., & Reith, D. M. (2012). An evaluation of a change in dosing regimen of gentamicin in neonates. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Australasian Pharmaceutical Science Association (APSA) Joint Conference: Medication Safety. (pp. 146). Retrieved from http://www.ascept-apsa.com/

Tomlin, A., Reith, D., Dovey, S., & Tilyard, M. (2012). An evaluation of switches in therapeutic equivalents as triggers for adverse event monitoring. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Australasian Pharmaceutical Science Association (APSA) Joint Conference: Medication Safety. (pp. 144). Retrieved from http://www.ascept-apsa.com/

Owens, K. H., Medlicott, N. J., Whyte, I. M., Buckley, N. A., & Reith, D. M. (2012). Development of a population PKPD model to describe the effect of paracetamol on the International Normalised Ratio (INR). Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Australasian Pharmaceutical Science Association (APSA) Joint Conference: Medication Safety. (pp. 142). Retrieved from http://www.ascept-apsa.com/

Ragupathy, R., Tordoff, J., Norris, P., & Reith, D. (2012). How changes to New Zealand's medicines regulation system will affect us. New Zealand Medical Journal, 125(1366). Retrieved from http://www.nzma.org.nz/journal

Curran, N., Thompson-Fawcett, M., Zacharias, M., Reith, D., Young, S., & Medlicott, N. (2012). The effect of major abdominal surgery on cytokine production. ANZ Journal of Surgery, 82(Suppl. 1), (pp. 76). doi: 10.1111/j.1445-2197.2012.06056.x

Owens, K., Murphy, P., Medlicott, N., Kennedy, J., Zacharias, M., Curran, N., Chary, S., Thompson-Fawcett, M., & Reith, D. (2012). The pharmacokinetic profile of intravenous paracetamol in adult patients undergoing major surgery: A population analysis. Proceedings of the Twenty-First Annual Meeting of the Population Approach Group in Europe (PAGE). 2394. Retrieved from http://www.page-meeting.org/default.asp?abstract=2394

Owens, K., Medlicott, N., Murphy, P., Kennedy, J., Zacharias, M., Chary, S., Curran, N., Thompson-Fawcett, M., & Reith, D. (2012). The pharmacokinetic profile of intravenous paracetamol in adult patients undergoing major abdominal surgery: A population analysis. Proceedings of the 14th Annual Population Approach Group in Australia and New Zealand Meeting (PAGANZ). Retrieved from http://www.paganz.org/conference/melbourne-2012-14th-annual-scientific-meeting

Conference Contribution - Poster Presentation (not in published proceedings)

Owens, K., Medlicott, N., Zacharias, M., Curran, N., Chary, S., Thompson-Fawcett, M., & Reith, D. (2012, September). The pharmacokinetic profile of intravenous paracetamol in adult patients undergoing major abdominal surgery. Poster session presented at the Division of Health Sciences Research Forum: Health Matters: Research Excellence at Otago, Dunedin, New Zealand.

Owens, K., Medlicott, N., Whyte, I., Buckley, N., & Reith, D. (2012, November-December). Development of a structural population PKPD model to describe the effect of paracetamol on the international normalised ratio (INR). Poster session presented at the 9th Biennial Globalization of Pharmaceutics Education Network (GPEN) Conference, Melbourne, Australia.

Conference Contribution - Verbal presentation and other Conference outputs

Ragupathy, R., Aaltonen, K., Tordoff, J., Norris, P., & Reith, D. (2012, August-September). Life in a nine dimensional universe: New Zealanders' access to pharmaceuticals. Verbal presentation at the New Zealand Hospital Pharmacists' Association Conference, Auckland, New Zealand.

Medlicott, N. J., Reith, D. M., McCaffrey, F., Krittaphol, W., & Broadbent, R. S. (2012, August-September). Infusion variables impact on delivery of gentamicin to neonates - especially low birth weight neonates. Verbal presentation at the New Zealand Hospital Pharmacists' Association Conference, Auckland, New Zealand.

2011

Chapter in Book - Research

Reith, D. (2011). Paediatric toxicology. In A. C. Moffatt, M. D. Osselton, B. Widdop & J. Watts (Eds.), Clarke's analysis of drugs and poisons (Vol. 1). (4th ed.) (pp. 429-444). London: Pharmaceutical Press.

Conference Contribution - Published proceedings: Abstract

Owens, K. H., Reith, D. M., Medlicott, N. J., Zacharias, M., & Chary, S. (2011). The effect of surgery on the glucuronidation and sulphation of paracetamol. Proceedings of the Population Approach Group in Australia and New Zealand Meeting (PAGANZ). PAGANZ. Retrieved from http://www.paganz.org/default.asp?id=45&keuze=program

Ragupathy, R., Aaltonen, K., Tordoff, J., Norris, P., & Reith, D. (2011). The effects of pharmaceutical cost containment on access to licensed and subsidized medicines under single payer systems in the United States, United Kingdom, Australia and New Zealand. Value in Health. 14(3), (pp. A14). doi: 10.1016/j.jval.2011.02.087

Conference Contribution - Poster Presentation (not in published proceedings)

Wheeler, B., Broadbent, R., & Reith, D. (2011, November). Premedication for intubation in Australasia: A survey of current neonatal practice. Poster session presented at the Paediatric Society of New Zealand 63rd Annual Scientific Meeting, Auckland, New Zealand.

Salis, E., Reith, D., & Medlicott, N. (2011, February). Liquid chromatography–mass spectrometry (LC-MS) analysis of insulin analogues for pharmacokinetic studies. Poster session presented at the New Zealand Chapter of the Controlled Release Society 13th Conference on Formulation and Delivery of Bioactives, Dunedin, New Zealand.

Owens, K., Reith, D., Medlicott, N., Zacharias, M., & Chary, S. (2011, February). The effect of surgery on the glucuronidation and sulphation of paracetamol. Poster session presented at the New Zealand Chapter of the Controlled Release Society 13th Conference on Formulation and Delivery of Bioactives, Dunedin, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Reith, D. (2011, July). Paediatric toxicology. Verbal presentation at the Australasian College for Emergency Medicine (ACEM) Winter Symposium, Queenstown, New Zealand.

Ragupathy, R., Tordoff, J., Norris, P., & Reith, D. (2011, November). Found in New Zealand and nowhere else: Kiwi, Rimu, Tuatara... PHARMAC? Verbal presentation at the New Zealand Hospital Pharmacists' Association Conference, Tauranga, New Zealand.

Reith, D. (2011, February). Provision of suitable formulations for children: A greater challenge than licensing? Invited presentation at the New Zealand Chapter of the Controlled Release Society 13th Conference on Formulation and Delivery of Bioactives, Dunedin, New Zealand.

2010

Journal - Research Article

Kunac, D. L., Kennedy, J., Austin, N. C., & Reith, D. M. (2010). Risk factors for adverse drug events and medication errors in paediatric inpatients: Analysis by admission characteristics. Journal of Pharmacy Practice & Research, 40(4), 290-293.

Wright, D. F. B., Al-Sallami, H. S., Jackson, P. M., & Reith, D. M. (2010). Falsely elevated vancomycin plasma concentrations sampled from central venous implantable catheters (portacaths). British Journal of Clinical Pharmacology, 70(5), 769-772. doi: 10.1111/j.1365-2125.2010.03749.x

Ragupathy, R., Tordoff, J., Norris, P., & Reith, D. (2010). Access to children's medicines in the United Kingdom, Australia and New Zealand in 1998, 2002 and 2007. Pharmacy World & Science, 32, 386-393. doi: 10.1007/s11096-010-9383-z

Aaltonen, K., Ragupathy, R., Tordoff, J., Reith, D., & Norris, P. (2010). The impact of pharmaceutical cost containment policies on the range of medicines available and subsidized in Finland and New Zealand. Value in Health, 13(1), 148-156. doi: 10.1111/j.1524-4733.2009.00598.x

Conference Contribution - Published proceedings: Abstract

Salis, E., Reith, D., & Medlicott, N. J. (2010). Liquid Chromatography-Mass Spectrometry (LCMS) analysis of insulin analogues for pharmacokinetic studies. In L. Emmerton, A. Peters, D. Ross & B. Ross (Eds.), Proceedings of the Australasian Pharmaceutical Science Association (APSA) Annual Conference: Focus on the Future: Research and Education for a Healthier Community. (pp. 113). APSA. [Abstract]

Ragupathy, R., Aaltonen, K., Tordoff, J., Norris, P., & Reith, D. (2010). Medicines licensed for children and subsidised under single payer systems in New Zealand, Australia, the United Kingdom and the United States. Pharmacy Practice. 8(Suppl. 1), (pp. 48-49). [Abstract]

Aaltonen, K., Ragupathy, R., Tordoff, J., Reith, D., & Norris, P. (2010). Delay in licensing new important innovative products that provide health gain in Finland and New zealand. Pharmacy Practice. 8(Suppl. 1), (pp. 85). [Abstract]

Fountain, J. S., & Reith, D. M. (2010). New Zealand and Australian emergency department sources of poisons information. Clinical Toxicology. 48(3), (pp. 271-272). [Abstract]

Conference Contribution - Poster Presentation (not in published proceedings)

Ragupathy, R., Aaltonen, K., Tordoff, J., Norris, P., & Reith, D. (2010, September). Medicines licensed for children and subsidised under single payer systems in New Zealand, Australia, the United Kingdom and the United States. Poster session presented at the Fourth Annual Division of Health Sciences Research Forum, Dunedin, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Salis, E., Reith, D., & Medlicott, N. J. (2010, February). LC-MS and chemiluminescence analysis of insulin analogues for pharmacokinetic studies. Verbal presentation at the New Zealand Chapter of the Controlled Release Society 12th Conference on Formulation and Delivery of Bioactives, Dunedin, New Zealand.

2009

Journal - Research Article

Sherwin, C. M. T., Kostan, E., Broadbent, R. S., Medlicott, N. J., & Reith, D. M. (2009). Evaluation of the effect of intravenous volume expanders upon the volume of distribution of gentamicin in septic neonates. Biopharmaceutics & Drug Disposition, 30(5), 276-280. doi: 10.1002/bdd.666

Sherwin, C. M. T., Svahn, S., Van Der Linden, A., Broadbent, R. S., Medlicott, N. J., & Reith, D. M. (2009). Individualised dosing of amikacin in neonates: A pharmacokinetic/pharmacodynamic analysis. European Journal of Clinical Pharmacology, 65(7), 705-713. doi: 10.1007/s00228-009-0637-4

Kunac, D. L., Kennedy, J., Austin, N., & Reith, D. (2009). Incidence, preventability, and impact of adverse drug events (ADEs) and potential ADEs in hospitalized children in New Zealand: A prospective observational cohort study. Pediatric Drugs, 11(2), 153-160. doi: 10.2165/00148581-200911020-00005

Young, L., Lawes, F., Tordoff, J., Norris, P., & Reith, D. (2009). Access to prescribing information for paediatric medicines in the USA: Post-modernization. British Journal of Clinical Pharmacology, 67(3), 341-346. doi: 10.1111/j.1365-2125.2008.03356.x

Sherwin, C. M. T., McCaffrey, F., Broadbent, R. S., Reith, D. M., & Medlicott, N. J. (2009). Discrepancies between predicted and observed rates of intravenous gentamicin delivery for neonates. Journal of Pharmacy & Pharmacology, 61(4), 465-471. doi: 10.1211/jpp/61.04.0008

Reith, D., Medlicott, N. J., De Silva, R. K., Yang, L., Hickling, J., & Zacharias, M. (2009). Simultaneous modelling of the Michaelis-Menten kinetics of paracetamol sulphation and glucuronidation. Clinical & Experimental Pharmacology & Physiology, 36(1), 35-42. doi: 10.1111/j.1440-1681.2008.05029.x

Journal - Research Other

Sherwin, C. M. T., Broadbent, R. S., Medlicott, N. J., & Reith, D. M. (2009). Individualised dosing of amikacin in neonates [Letter to the editor]. European Journal of Clinical Pharmacology, 65(12), 1267-1268. doi: 10.1007/s00228-009-0691-y

Conference Contribution - Published proceedings: Abstract

Reith, D., Owens, K., Svahn, S., Broadbent, R., Medlicott, N., & Sherwin, C. (2009). A pharmacokinetic pharmacodynamic study of hearing impairment in neonates treated with aminoglycosides using a logistic regression model. Basic & Clinical Pharmacology & Toxicology, 105(Suppl. 1), (pp. 131). doi: 10.1111/j.1742-7843.2009.00437.x

Conference Contribution - Poster Presentation (not in published proceedings)

Ragupathy, R., Tordoff, J., Norris, P., & Reith, D. (2009, September). Availability of prescription medicines licensed for adults in New Zealand, Australia, the United Kingdom and the United States, and the subsidy of medicines licensed for adults under a government funded single payer system in each country. Poster session presented at the Third Annual Division of Health Sciences Research Forum, Wellington, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Aaltonen, K., Ragupathy, R., Tordoff, J., Reith, D., & Norris, P. (2009, June). The impact of pharmaceutical cost containment policies on the range of medicines available and subsidised in Finland and New Zealand. Verbal presentation at the 4th Nordic Social Pharmacy and Health Services Research Conference: Increasing the Impact of Social Pharmacy Research, Oslo, Norway.

Working Paper; Discussion Paper; Technical Report

Horsburgh, S., Malik, M., Norris, P., Harrison-Woolrych, M., Tordoff, J., Becket, G., Herbison, P., Parkin, L., & Reith, D. (2009). Prescribing and dispensing data sources in New Zealand: Their usage and future directions [Technical Report No. 001/09]. Dunedin, New Zealand: School of Pharmacy, University of Otago. 63p.

2008

Journal - Research Article

Kunac, D. L., & Reith, D. M. (2008). Preventable medication-related events in hospitalised children in New Zealand. New Zealand Medical Journal, 121(1272), 17-32. Retrieved from http://journal.nzma.org.nz/journal/121-1272/3012/content.pdf

Sherwin, C., Broadbent, R., Young, S., Worth, J., McCaffrey, F., Medlicott, N. J., & Reith, D. (2008). Utility of interleukin-12 and interleukin-10 in comparison with other cytokines and acute-phase reactants in the diagnosis of neonatal sepsis. American Journal of Perinatology, 25, 629-636. doi: 10.1055/s-0028-1090585

Tordoff, J., Norris, P., Ragupathy, R., & Reith, D. (2008). Are New Zealand children still therapeutic orphans? Childrenz Issues, 12(1), 12-15.

Tordoff, J. M., Norris, P. T., & Reith, D. M. (2008). ″Price management″ and its impact on hospital pharmaceutical expenditure and the availability of medicines in New Zealand hospitals. Value in Health, 11(7), 1214-1226. doi: 10.1111/j.1524-4733.2008.00353.x

Sherwin, C. M. T., Broadbent, R. S., Medlicott, N. J., & Reith, D. M. (2008). Individualising netilmicin dosing in neonates. European Journal of Clinical Pharmacology, 64, 1201-1208. doi: 10.1007/s00228-008-0536-0

Journal - Research Other

Sherwin, C. M. T., Svahn, S., Broadbent, R. S., Van Der Linden, A., Medlicott, N. J., & Reith, D. M. (2008). Netilmicin withdrawal: Impact on neonates [Letter]. New Zealand Medical Journal, 121(1284). Retrieved from http://journal.nzma.org.nz/journal/121-1284/3328/content.pdf

Journal - Professional & Other Non-Research Articles

Sherwin, C., Medlicott, N., Broadbent, R., & Reith, D. (2008). Neonatal sepsis and aminoglycosides. Pharmacy Journal of New Zealand, (April), 16-20.

Conference Contribution - Published proceedings: Abstract

Owens, K., Sherwin, C., Reith, D., & Medlicott, N. (2008). Evaluating gentamicin and ototoxicity in neonates to optimise development of a new dosing regimen. New Zealand Medical Journal, 121(1274). Retrieved from http://journal.nzma.org.nz/journal/121-1274/3078/content.pdf

Tordoff, D., Reith, D., & Chesney, K. (2008). Developing a personal formulary: Helping students get to grips with clinical pharmacology. A CALT supported development. In C. Bond & R. Spronken-Smith (Eds.), Proceedings of the Spotlight on Teaching at Otago Conference. (pp. 38). Dunedin, New Zealand: HEDC, University of Otago. [Abstract]

Owens, K., Sherwin, C. M. T., Broadbent, R., Reith, D. M., & Medlicott, N. J. (2008). Investigation of hearing impairment in neonates treated with aminoglycosides. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Annual Scientific Meeting. ASCEPT. Retrieved from http://phal.otago.ac.nz/ascept_docos/programme%202008.pdf

Reith, D. M. (2008). E-prescribing revisited. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Annual Scientific Meeting. ASCEPT. Retrieved from http://phal.otago.ac.nz/ascept_docos/programme%202008.pdf

Sherwin, C. M. T., Svahn, S., van der Linden, A. J., Medlicott, N. J., Broadbent, R., & Reith, D. M. (2008). Withdrawing medicines used to treat infections in neonates may increase the risk of treatment failure. In C. Matthewson & M. Taumoepeau (Eds.), Proceedings of the Pacific Postgraduate Symposium: Pacific Voices V. (pp. 41). Dunedin, New Zealand: Pacific Islands Centre, University of Otago. [Abstract]

Sherwin, C. M. T., Svahn, S., Medlicott, N. J., Broadbent, R., & Reith, D. M. (2008). Pharmacodynamic analysis of hearing impaired neonates treated with amikacin. Proceedings of the American Conference on Pharmacometrics. ACOP. Retrieved from http://tucson2008.go-acop.org/pdfs/Sherwin.pdf

Medlicott, N. J., Rizi, K., Yang, L., Zacharias, M., De Silva, R. K., & Reith, D. M. (2008). Does reduced dissolution of paracetamol contribute to delayed absorption following single 60 and 90 mg/kg doses in third molar extractions? Journal of Pharmacy and Pharmacology. (Suppl. 1), (pp. A-33-A-34). [Abstract]

Medlicott, N. J., Sherwin, C., Broadbent, R., McCaffrey, F., & Reith, D. (2008). Intravenous infusions of gentamicin in neonate patients: Effects of infusion variables on drug administration rates. Journal of Pharmacy and Pharmacology. (Suppl. 1), (pp. A-11). [Abstract]

Sherwin, C. M. T., Svahn, S., Van Der Linden, A. J., Medlicott, N. J., Broadbent, R., & Reith, D. M. (2008). Simulation of an optimal pharmacokinetic and pharmacodynamic amikacin dosing regimen for neonates. Proceedings of the 10th Annual Population Approach Group in Australia and New Zealand Conference. PAGANZ. Retrieved from http://www.paganz.org/default.asp?abstract=1077

Sherwin, C. M. T., Medlicott, N. J., Broadbent, R., & Reith, D. M. (2008). Simulation and development of a netilmicin extended dosing regimen for extremely premature neonates. Proceedings of the Seventeenth Meeting of the Population Approach Group in Europe. PAGE. Retrieved from http://www.page-meeting.org/default.asp?abstract=1241

Ragupathy, R., Tordoff, J., Norris, P., & Reith, D. (2008). Children's access to prescription medicines in New Zealand, the UK and Australia 1998-2007. International Journal of Pharmacy Practice. 16(Suppl. 2), (pp. B29). doi: 10.1211/096176708784658297

Tordoff, J., Young, L., Lawes, F., Norris, P., & Reith, D. (2008). Has a decade of incentives improved access to medicines for children in the USA? International Journal of Pharmacy Practice. 16(Suppl. 2), (pp. B28-B29). doi: 10.1211/096176708784658297

Conference Contribution - Verbal presentation and other Conference outputs

Sherwin, C. M. T., Medlicott, N. J., Broadbent, R., & Reith, D. M. (2008, June). Investigation into the intravenous delivery of aminoglycoside antibiotics to extremely premature neonates. Verbal presentation at the 11th Biannual European Society for Developmental Perinatal and Paediatric Pharmacology Congress, Rotterdam, The Netherlands.

2007

Journal - Research Article

Reith, D. M., & Edmonds, L. (2007). Assessing the role of drugs in suicidal ideation and suicidality. CNS Drugs, 21(6), 463-472.

Zacharias, M., De Silva, R. K., Hickling, J., Medlicott, N. J., & Reith, D. M. (2007). Comparative safety and efficacy of two high dose regimens of oral paracetamol in healthy adults undergoing third molar surgery under local anaesthesia. Anaesthesia & Intensive Care, 35(4), 544-549.

Balakrishnan, K., Tordoff, J., Norris, P., & Reith, D. (2007). Establishing a baseline for the monitoring of medicines availability for children in the UK: 1998-2002. British Journal of Clinical Pharmacology, 63(1), 85-91.

Conference Contribution - Published proceedings: Abstract

Sherwin, C. M. T., Svahn, S., Van Der Linden, A. J., Medlicott, N. J., Broadbent, R., & Reith, D. M. (2007). A pharmacokinetic/pharmacodynamic model to determine optimal dosing targets for amikacin in neonatal sepsis. Proceedings of the Population Approach Group in Europe Sixteenth Annual Meeting. PAGE. Retrieved from http://www.page-meeting.org/default.asp?abstract=1134

Sherwin, C. M. T., Broadbent, R., Medlicott, N. J., & Reith, D. M. (2007). Investigation into the diagnosis of neonatal sepsis and improvement of treatment utilising the pharmacokinetics of aminoglycosides. In C. Matthewson & M. Taumoepeau (Eds.), Proceedings of the Pacific Postgraduate Symposium: Pacific Voices IV. (pp. 37). Dunedin, New Zealand: Pacific Islands Centre, University of Otago. [Abstract]

Tordoff, J. M., Norris, P. T., & Reith, D. M. (2007). The impact of PHARMAC's 'Price Management' on hospital pharmaceutical expenditure and the availability of medicines in New Zealand hospitals. Proceedings of the New Zealand Hospital Pharmacists' Association Conference. Retrieved from http://www.confer.co.nz/nzhpa2007/programme.html

Tordoff, J. M., Norris, P. T., & Reith, D. M. (2007). Three years of 'Price Management' and its impact on hospital pharmaceutical expenditure in New Zealand. International Journal of Pharmacy Practice. (Suppl. 2), (pp. B44-B45). [Abstract]

Conference Contribution - Verbal presentation and other Conference outputs

Kunac, D. L., Kennedy, J., Austin, N. C., & Reith, D. M. (2007, November). Adverse drug events and medication errors in a neonatal intensive care unit: Risk factors and time to event analysis. Verbal presentation at the Paediatric Society of New Zealand 59th Annual Scientific Meeting, Christchurch, New Zealand.

Sherwin, C. M. T., Kostan, E., Medlicott, N. J., Broadbent, R., & Reith, D. M. (2007, August). The effect upon volume of distribution of intravenous volume expanders delivered to neonates treated with gentamicin for suspected sepsis. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists & Toxicologists (NZ) Annual Scientific Meeting, Auckland, New Zealand.

2006

Journal - Research Article

Balakrishnan, K., Grieve, J., Tordoff, J., Norris, P., & Reith, D. (2006). Pediatric licensing status and the availability of suitable formulations for new medical entities approved in the United States between 1998 and 2002. Journal of Clinical Pharmacology, 46(9), 1038-1043.

Kunac, D. L., Reith, D. M., Kennedy, J., Austin, N. C., & Williams, S. M. (2006). Inter- and intra-rater reliability for classification of medication related events in paediatric inpatients. Quality & Safety in Health Care, 15, 196-201.

Tordoff, J. M., Murphy, J. E., Norris, P. T., & Reith, D. M. (2006). Use of centrally developed pharmacoeconomic assessments for local formulary decisions. American Journal of Health-System Pharmacy, 63(17), 1613-1618.

Tordoff, J., Norris, P., Kennedy, J., & Reith, D. (2006). The influence of PHARMAC's National Hospital Pharmaceutical Strategy on quality use of medicines activities in New Zealand hospitals. New Zealand Medical Journal, 119(1239). Retrieved from http://journal.nzma.org.nz/journal/119-1239/2100/content.pdf

Grant, K., Al-Adhami, N., Tordoff, J., Livesey, J., Barbezat, G., & Reith, D. (2006). Continuation of proton pump inhibitors from hospital to community. Pharmacy World & Science, 28(4), 189-193.

Didham, R., Dovey, S., & Reith, D. (2006). Characteristics of general practitioner consultations prior to suicide: A nested case-control study in New Zealand. New Zealand Medical Journal, 119(1247). Retrieved from http://journal.nzma.org.nz/journal/119-1247/2358/content.pdf

Conference Contribution - Published proceedings: Abstract

Hickling, J. M., De Silva, R. K., Zacharias, M., Reith, D., & Medlicott, N. (2006). Comparison of two different doses of paracetamol for pain relief in day care dental procedures. Anaesthesia & Intensive Care, 34(4), (pp. 544-545). [Abstract]

Tordoff, J., Norris, P., & Reith, D. (2006). Impact of a three-part strategy to manage hospital pharmaceutical expenditure in New Zealand. The International Journal of Pharmacy Practice. 14(Suppl. 1), (pp. A34). [Abstract]

Sherwin, C. M. T., Svahn, S., Medlicott, N., Broadbent, R., & Reith, D. M. (2006). Population pharmacokinetics of amikacin in extremely low birth weight to term neonates. AAPS Journal, 8(S2). Retrieved from http://www.aapsj.org/abstracts/AM_2006/AAPS2006-000310.pdf

2005

Journal - Research Article

Fountain, J. S., Reith, D. M., & Watts, M. (2005). Comparison of CD-Rom and Internet access to clinical information. International Journal of Medical Informatics, 74(9), 769-777.

Tordoff, J. M., Norris, P. T., Kennedy, J. M., & Reith, D. M. (2005). Influence of the National Hospital Pharmaceutical Strategy on the assessment of new medicines in New Zealand public hospitals. Journal of Pharmacy Practice & Research, 35(4), 271-275.

Didham, R. C., McConnell, D. W., Blair, H. J., & Reith, D. M. (2005). Suicide and self-harm following prescription of SSRIs and other antidepressants: Confounding by indication. British Journal of Clinical Pharmacology, 60(5), 519-525.

Lingvall, M., Reith, D., & Broadbent, R. (2005). The effect of sepsis upon gentamicin pharmacokinetics in neonates. British Journal of Clinical Pharmacology, 59(1), 54-61.

Carter, G., Reith, D. M., Whyte, I. M., & McPherson, M. (2005). Non-suicidal deaths following hospital-treated self-poisoning. Australian & New Zealand Journal of Psychiatry, 39, 101-107.

Kunac, D. L., & Reith, D. M. (2005). Identification of priorities for medication safety in neonatal intensive care. Drug Safety, 28(3), 251-261.

Carter, G., Reith, D. M., Whyte, I. M., & McPherson, M. (2005). Repeated self-poisoning: Increasing severity of self-harm as a predictor of subsequent suicide. British Journal of Psychiatry, 186, 253-257.

Reith, D., Fountain, J., & Tilyard, M. (2005). Opioid poisoning deaths in New Zealand (2001-2002). New Zealand Medical Journal, 118(1209). Retrieved from http://journal.nzma.org.nz/journal/118-1209/1293/content.pdf

Didham, R. C., Reith, D. M., McConnell, D. W., & Harrison, K. S. (2005). Antibiotic exposure and breast cancer in New Zealand. Breast Cancer Research & Treatment, 92, 163-167.

Grieve, J., Tordoff, J., Reith, D., & Norris, P. (2005). Effect of the Pediatric Exclusivity Provision on children's access to medicines. British Journal of Clinical Pharmacology, 59(6), 730-735.

Chui, J., Tordoff, J., & Reith, D. (2005). Changes in availability of paediatric medicines in Australia between 1998 and 2002. British Journal of Clinical Pharmacology, 59(6), 736-742.

Tordoff, J. M., Norris, P. T., & Reith, D. M. (2005). Managing prices for hospital pharmaceuticals: A successful strategy for New Zealand? Value in Health, 8(3), 201-208.

Tordoff, J., Norris, P., Kennedy, J., & Reith, D. (2005). Quality use of medicines activities in New Zealand hospitals from 2000 to 2002. New Zealand Medical Journal, 118(1208). Retrieved from http://journal.nzma.org.nz/journal/118-1208/1259/content.pdf

Journal - Research Other

Wheeler, B., Taylor, B., Simonsen, K., & Reith, D. M. (2005). Melatonin treatment in Smith Magenis syndrome [Letter to the editor]. Sleep, 28(12), 1609-1610.

Reith, D. M., Fountain, J. S., & Tilyard, M. (2005). 'Opioid poisoning deaths in New Zealand (2001-2002)' and the UK's recent decision to withdraw the pain killer coproxamol [Letter]. New Zealand Medical Journal, 118(1209). Retrieved from http://journal.nzma.org.nz/journal/118-1209/1294/content.pdf

Conference Contribution - Published proceedings: Abstract

Tordoff, J., Norris, P., & Reith, D. (2005). PHARMAC's economic assessments of new medicines and their use in New Zealand hospitals. Proceedings of the Joint Meeting of ASCEPT and APSA. (Oral 156). [Abstract]

Conference Contribution - Poster Presentation (not in published proceedings)

Tordoff, J., Norris, P., & Reith, D. (2005, September). PHARMAC's National Hospital Pharmaceutical Strategy and its influence on the assessment of new medicines in New Zealand hospitals by 2004. Poster session presented at the Proceedings of the Joint Conference of the Pharmaceutical Society of New Zealand and the New Zealand Pharmacy Conference: Bridging the gap, Auckland, New Zealand.

2004

Journal - Research Article

Reith, D. M., Whyte, I., Carter, G., McPherson, M., & Carter, N. (2004). Risk factors for suicide and other deaths following hospital treated self-poisoning in Australia. Australian & New Zealand Journal of Psychiatry, 38(7), 520-525.

McEniery, J. A., Delbridge, R. G., & Reith, D. M. (2004). Infant pertussis deaths and the management of cardiovascular compromise. Journal of Paediatrics & Child Health, 40, 230-232.

Watts, M., Fountain, J. S., Reith, D., & Schep, L. (2004). Compliance with Poisons Center referral advice and implications for toxicovigilance. Journal of Toxicology: Clinical Toxicology, 42(5), 603-610.

Tordoff, J. M., Norris, P., Kennedy, J. M., & Reith, D. M. (2004). Processes for the assessment and introduction of new medicines in New Zealand hospitals. Journal of Pharmacy Practice & Research, 34(4), 267-271.

Chui, J., Tordoff, J., Kennedy, J., & Reith, D. (2004). Trends in accessibility to medicines for children in New Zealand: 1998-2002. British Journal of Clinical Pharmacology, 57(3), 322-327.

Conference Contribution - Published proceedings: Abstract

Lingvall, M., Reith, D. M., & Broadbent, R. (2004). The effect of disease states upon gentamicin pharmacokinetics in neonates. Clinical and Experimental Pharmacology and Physiology. 31(Suppl. 1), (pp. A104). [Abstract]

Lingvall, M., Reith, D. M., & Broadbent, R. S. (2004). Gentamicin pharmacokinetics in newborn infants. Proceedings of the 8th Annual Congress of the Perinatal Society of Australia and New Zealand. (pp. 78). Australia: Perinatal Society of Australia and New Zealand. [Abstract]

Grant, K., Muhsin, N. A., Tordoff, J., Livesey, J., Barbezat, G., & Reith, D. (2004). Proton pump inhibitors: Prescribing at the interface. Proceedings of the New Zealand HealthCare Pharmacists' Association Conference. (pp. 37). New Plymouth, New Zealand: NZHPA. [Abstract]

Tordoff, J., Norris, P., & Reith, D. (2004). Impact of the first year of 'Price Management' for hospital pharmaceuticals in New Zealand. Proceedings of the New Zealand HealthCare Pharmacists' Association Conference. (pp. 51). New Plymouth, New Zealand: NZHPA. [Abstract]

Grieve, J. S., Tordoff, J. M., Norris, P. T., & Reith, D. M. (2004). Have US ″Paediatric Exclusivity″ provisions widened children's access to medicines in the US compared to other countries? Proceedings of the National Medicines Symposium. (pp. 63-64). Australia: NPS/PHARM. [Abstract]

2003

Journal - Research Article

Reith, D. M., Whyte, I., & Carter, G. (2003). Repetition risk for adolescent self-poisoning: A multiple event survival analysis. Australian & New Zealand Journal of Psychiatry, 37(2), 212-218.

Reith, D. M., Whyte, I., Carter, G., & McPherson, M. (2003). Adolescent self-poisoning: A cohort study of subsequent suicide and premature deaths. Crisis, 24(2), 79-84. doi: 10.1027//0227-5910.24.2.79

Reith, D. M., O'Regan, P., Bailey, C., & Acworth, J. (2003). Serious lead poisoning in childhood: Still a problem after a century. Journal of Paediatrics & Child Health, 39, 623-626.

Hwang, C., Foot, C., Eddie, G., Johnson, L., & Reith, D. M. (2003). The utility of the history and clinical signs of poisoning in childhood: A prospective study. Therapeutic Drug Monitoring, 25(5), 728-734.

Rush, J. A., & Reith, D. M. (2003). Information sources accessed by parents following childhood poisoning. Paediatric Emergency Medicine, 15, 348-352.

Reith, D. M., Burke, C., Appleton, D. B., Wallace, G., & Pelekanos, J. (2003). Tolerability of topiramate in children and adolescents. Journal of Paediatrics & Child Health, 39, 416-419.

Westhuyen, J., Endre, Z. H., Reece, G., Reith, D. M., Saltissi, D., & Morgan, T. J. (2003). Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrology Dialysis Transplantation, 18(3), 543-551.

Reith, D., Fountain, J., Tilyard, M., & McDowell, R. (2003). Antidepressant poisoning deaths in New Zealand for 2001. New Zealand Medical Journal, 116(1184). Retrieved from http://journal.nzma.org.nz/journal/116-1184/646/content.pdf

Reith, D. M., Fountain, J., McDowell, R., & Tilyard, M. (2003). Comparison of the fatal toxicity index of zopiclone with benzodiazepines. Journal of Toxicology: Clinical Toxicology, 41(7), 975-980.

Johansson, M., Hall, J., Reith, D. M., Jackson, P., & Tilyard, M. (2003). Trends in the use of inhaled corticosteroids for childhood asthma in New Zealand. European Journal of Clinical Pharmacology, 59, 483-487.

Watts, M., Fountain, J., Reith, D. M., & Herbison, G. P. (2003). Clinical utility of an electronic poisons information and clinical decision support tool. International Journal of Medical Informatics, 71, 3-8.

Conference Contribution - Published proceedings: Abstract

Tordoff, J. M., Norris, P., Kennedy, J., & Reith, D. M. (2003). Processes for the assessment of new medicines in New Zealand hospitals. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists. (pp. 1-16). [Abstract]

Hwang, C., Foot, C., Eddie, G., Johnson, L. W., & Reith, D. M. (2003). The utility of the history and clinical signs of poisoning in childhood: A prospective study. Australasian College of Emergency Medicine Annual Scientific Meeting 2003. 15(2), (pp. A23). Sydney, Australia: Blackwell Publishing. [Abstract]

Conference Contribution - Poster Presentation (not in published proceedings)

Chui, J., Tordoff, J. M., Kennedy, J. M., & Reith, D. M. (2003, August). Availability of medicines for children in New Zealand. Poster session presented at the Paediatric Society of New Zealand Annual Scientific Meeting, Queenstown, New Zealand.

2002

Journal - Research Article

de la Porte, M., Reith, D. M., & Tilyard, M. (2002). Impact of safety alerts upon prescribing of cisapride to children in New Zealand. New Zealand Medical Journal, 115(1157), U24. Retrieved from www.nzma.org.nz/journal/115-1157/24

Journal - Professional & Other Non-Research Articles

Reith, D. M. (2002). Off label prescribing in children. British Medical Journal, 325(7359), 338.

Conference Contribution - Published proceedings: Abstract

Reith, D. M., Whyte, I., Carter, G., & McPherson, M. (2002). Methods in toxicovigilance: Data linking of large databases. The Australian Health & Medical Research Congress. 1, (pp. 2151). Melbourne, Australia: Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists. [Abstract]

Reith, D. M., Burke, C., Appleton, D., Wallace, G., & Pelekanos, J. (2002). Topiramate utilisation in a paediatric population. Royal Australasian College of Physicians Annual Scientific Meeting. 38(5), (pp. A16). Brisbane, Australia: Journal of Paediatrics and Child Health. [Abstract]

2001

Journal - Research Article

Reith, D. M., Andrews, J., & McLaughlin, D. (2001). Valproic acid has temporal variability in urinary clearance of metabolites. Chronobiology International, 18(1), 123-129.

Reith, D. M., Pitt, W. R., & Hockey, R. (2001). Childhood poisoning in Queensland: An analysis of presentation and admission rates. Journal of Paediatrics & Child Health, 37(5), 446-450.

Baer, E., & Reith, D. M. (2001). Acetazolamide poisoning in a toddler. Journal of Paediatrics & Child Health, 37(4), 411-412.

Reith, D. M., Hooper, W. D., Parke, J., & Charles, B. (2001). Population pharmacokinetic modeling of steady state carbamazepine clearance in children, adolescents and adults. Journal of Pharmacokinetics & Pharmacodynamics, 28(1), 79-92. doi: 10.1023/A:1011569703060

Conference Contribution - Published proceedings: Abstract

Reith, D. M., O'Regan, P., Bailey, C., & Knight, P. (2001). Lead poisoning: Experience of chelation therapy. ASCEPT. 9, (pp. 54). [Abstract]

2000

Journal - Research Article

Whyte, I. M., Buckley, N. A., Reith, D. M., Goodhew, I., Seldom, M., & Dawson, A. H. (2000). Acetaminophen causes an increased INR by reducing functional factor VII. Therapeutic Drug Monitoring, 22(6), 742-748.

Reith, D. M., Andrews, J., Parker-Scott, S. L., & Eadie, M. J. (2000). Urinary excretion of Valproate metabolites in children and adolescents. Biopharmaceutics & Drug Disposition, 21(8), 327-330.

Reith, D. M., Appleton, D. B., Hooper, W. D., & Eadie, M. J. (2000). The effect of body size on the metabolic clearance of carbamazepine. Biopharmaceutics & Drug Disposition, 21, 103-111.

Healy, H., Reith, D., Morgan, C., Clague, D. A., & Westhuizen, J. (2000). Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure? Annals of Clinical & Laboratory Science, 30(3), 295-304.

Conference Contribution - Published proceedings: Abstract

Reith, D. M., Pitt, W. R., & Hockey, R. (2000). Application of an injury surveillance database in the epidemiology of paediatric poisonings. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT). 8, (pp. 16). [Abstract]

Dickinson, R. G., Eadie, M. J., Addison, R. S., Parker-Scott, S. L., Reith, D. M., & Hooper, W. D. (2000). Aspects of time- and concentration-related beta-oxidation of Valproate in humans. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT). 8, (pp. 121). [Abstract]

1999

Journal - Research Article

Reith, D. M., & Cannell, G. (1999). A HPLC assay for carbamazepine phase I metabolites and their glucuronides in urine. Journal of Liquid Chromatography & Related Technologies, 22(12), 1805-1811.

Buckley, N. A., Dawson, A. H., Whyte, I. M., & Reith, D. M. (1999). Preformatted admission charts for poisoning admissions facilitate clinical assessment and research. Annals of Emergency Medicine, 34(4, Part 1), 476-482.

Conference Contribution - Published proceedings: Abstract

Reith, D. M., Charles, B., Hooper, W. D., & Parke, J. (1999). Validation of population pharmacokinetic models of carbamazepine. ASCEPT. 6, (pp. 50). [Abstract]

Conference Contribution - Verbal presentation and other Conference outputs

Reith, D. M., & Charles, B. (1999). Population pharmacokinetics of carbamazepine in children and adults: Combining steady state bioequivalence data and therapeutic drug monitoring data. Verbal presentation at the PAGANZ

1998

Journal - Research Article

Reith, D., Monteleone, J. P. R., Ebelling, B., Holford, N. H. G., Carter, G., & Whyte, I. M. (1998). Features and toxicokinetics of Clozapine in overdose. Therapeutic Drug Monitoring, 20(1), 92-97.

Conference Contribution - Published proceedings: Abstract

Reith, D., Appleton, D. B., Hooper, W. D., & Eadie, M. J. (1998). Relative liver size is the major determinant of the metabolic clearance of carbamazepine in children and adolescents. Australasian Society of Clinical Experimental Pharmacologists and Toxicologists. 2, (pp. A34). [Abstract]

Conference Contribution - Verbal presentation and other Conference outputs

Reith, D., Andrews, J., & McLaughlin, D. (1998). Valproic acid has diurnal variability in urinary clearance of metabolites. Verbal presentation at the RBH Healthcare Symposium, .

1997

Conference Contribution - Verbal presentation and other Conference outputs

Reith, D. M., & Andrews, J. (1997). CHanges in Valproate from childhood to adulthood. Verbal presentation at the ASCEPT